Gut oralisation signatures in Parkinson's disease: an integrative multi-study analysis.

Gabriela Durão, Emile Boyer, Martine Bonnaure-Mallet, Marc Verin, Manon Auffret, Vincent Meuric

Journal: Journal of oral microbiology 2026;18(1):2737700

PMID: 42866484

Abstract

BACKGROUND

Parkinson's disease (PD) compromises oral hygiene and oral health, potentially increasing oral bacterial input to the gut. Whether PD is associated with reproducible faecal enrichment of oral disease-linked taxa remains unclear.

OBJECTIVE

To determine whether oral disease-linked taxa are enriched in the faecal microbiota of individuals with PD.

METHODS

We conducted a pooled re-analysis of 23 faecal 16S rRNA datasets, comprising 3,594 PD and control samples. eHOMD was used to resolve oral-associated taxa, including caries/endodontic- and periodontitis-linked taxa. SILVA-based profiles were used to assess community diversity and ordination patterns. Differential-abundance analyses accounted for variation between studies.

RESULTS

PD samples showed heterogeneous but reproducible enrichment of oral disease-linked taxa, with a prominent caries/endodontic-associated component. The cariogenic-enriched subgroup showed reduced evenness and increased representation of oral taxa including Streptococcus mutans. Beta-diversity analyses showed substantial PD-control overlap and an oralization-related compositional gradient rather than a discrete PD-specific cluster.

CONCLUSIONS

This pooled re-analysis identifies a gut oralization-associated signal in a subset of individuals with PD. Faecal enrichment of oral-associated taxa may represent one component of gut microbiome heterogeneity and may indirectly reflect variation in oral ecosystem status, supporting oral health assessment in future PD microbiome studies.

© 2026 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

Address: INSERM, INRAE, UMR 1317, Nutrition, Metabolisms and Cancer (NuMeCan) Institute, Université de Rennes, Rennes, France.; Brain-Clinicial and Experimental Neuroplasticity (B-CLINE), Laboratoire Interdisciplinaire pour l'Innovation et la Recherche en Santé d'Orléans (LI2RSO), Université d'Orléans, Orléans, France.; Neurology Department, CHU d'Orléans, Orléans, France.; France Développement Electronique (FDE), Monswiller, France.; CIC 1414, CHU de Rennes - Université de Rennes, Rennes, France.; INSERM, INRAE, UMR 1317, Nutrition, Metabolisms and Cancer (NuMeCan) Institute, Université de Rennes, Rennes, France.; CIC 1414, CHU de Rennes - Université de Rennes, Rennes, France.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.